Kappa-free light chain as a practical alternative to oligoclonal bands in multiple sclerosis diagnosis | Synapse
March 3, 2026
Kappa-free light chain as a practical alternative to oligoclonal bands in multiple sclerosis diagnosis
Key Points
Kappa-free light chains demonstrate higher diagnostic accuracy for multiple sclerosis than traditional oligoclonal bands.
The analysis identifies a crucial shift in diagnostic practices for multiple sclerosis, showing improved sensitivity and specificity.
Assessment of diagnostic biomarkers reveals significant potential for kappa-free light chains in clinical settings.
Kappa-free light chains as a biomarker may enable better differentiation in multiple sclerosis diagnosis, suggesting broader implications for patient management.